English

25 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 27.8%

Biological products: 27.8%

Biosimilars: 20.4%

Hospital products: 20.4%

Innovative medicines: 38.7%

more info




Partnering Strategy/Interests

In-licensing: 33.3%

Out-licensing: 25.9%

Co-marketing: 22.2%

Co-promotion: 22.2%

Co-development: 31.5%

more info




Therapeutic areas

Cardiovascular: 31.5%

CNS: 38.9%

Infectious diseases: 24.1%

Pain: 31.5%

Respiratory: 18.5%

more info



PARTICIPANTS 2016

Allergy/immunology: 11.1%

Cardiovascular: 31.5%

CNS: 38.9%

Dentistry: 3.7%

Dermatology: 9.3%

Drug delivers technol.: 15.7%

Gastroenterology: 13.0%

Gerontology: 5.6%

Gynecology: 13.0%

Infectious diseases: 24.1%

Hematology: 9.2%

Ophthalmology: 8.3%

Oncology: 15.7%

Orthopedics: 9.3%

Pain: 31.5%

Pediatrics: 7.4%

Psychiatrics: 10.2%

Respiratory: 18.5%

Rheumatology: 12.0%

Urology: 6.5%

Vaccines: 4.6%

partner